BNTC
Benitec Biopharma Ltd ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$376.46M
P/E Ratio
—
EPS
$-1.08
Beta
0.12
52W High
$17.15
52W Low
$9.85
50-Day MA
$11.40
200-Day MA
$12.74
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Benitec Biopharma Ltd ADR
Benitec Biopharma Inc., a developing biotechnology company, is focused on the development of new genetic drugs. The company is headquartered in Hayward, California.
Fundamentals
| Revenue (TTM) | 7,000 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-48.30M |
| Operating Margin | 0.00% |
| Return on Equity | -33.50% |
| Return on Assets | -22.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $5.47 |
| Price-to-Book | 2.00 |
| Price-to-Sales (TTM) | 2770.13 |
| EV/Revenue | 10457.68 |
| EV/EBITDA | 850.87 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 12.50% |
| Shares Outstanding | $34.25M |
| Float | $17.83M |
| % Insiders | 2.71% |
| % Institutions | 96.36% |
Analyst Ratings
Consensus ($24.17 target)
1
Strong Buy6
BuyData last updated: 4/7/2026